Pherecydes Pharma is a SA (Société anonyme à directoire et conseil de surveillance) incorporated in December 2006. The company strategy is to invest in innovation, to build added value through patents and technology platforms. Today our advances hold promises in several business areas from drug discovery to companion diagnostic. At this stage of development Pherecydes Pharma is open to addede-value pharmaceutical developments.
Checking bacteriophage in vitro efficacy on multiresistant pathogenic bacteria strains.
The lab-operator is protected from pathogenic organisms for safety
A state of the art facility within Biocitech Technology Park
- An ideal situation within a secured park dedicated to biotechnology and other high technology fields
- Pherecydes Pharma holds the right to operate with harmful bacteria and genetically modified organisms
- Pherecydes Pharma manages 600 m² of laboratories at Biocitech, including an isolated new L2 area, dedicated to infectious bacteria